Table 3.
Study | Medication | Performance measure | Performance effect | |
---|---|---|---|---|
Dufka et al. [16] | Methamphetamine | Cycling | No effect on distance travelled (p = 0.81) | (−) |
Altszuler et al. [18] | Methylphenidate | Badminton | Medication led to improved performance in knowledge in recreation condition. Only sportsmanship and effort improved on medication by counselor rating (p < .01). Sports training and medication both significantly improved rule violations (p < .05, p < .001) | (+) |
King et al. [19] | Methylphenidate | Handgrip | Mean force over all trials significantly higher in methylphenidate group (p = 0.032) | (+) |
Roelands et al. [20] | Methylphenidate | Cycling | Methylphenidate increased exercise performance in warm conditions (p = 0.049). Power output was greater in methylphenidate group (p = 0.028) | (+) |
Cordery et al. [21] | Bupropion | Cycling | Total work significantly higher in bupropion trial (7.5 ± 9.6% increase; p = 0.042) | (+) |
Piacentini et al. [22] | Bupropion | Cycling | No difference in exercise performance (time to compete target amount of work) | (−) |
Roelands et al. [23] | Bupropion | Cycling | No significant differences in timed trial or max power output in bupropion trial versus placebo | (−) |
Chandler and Blair [17] | Amphetamine | Multiple (cycling, running, strength) | Acceleration (p < 0.05), knee extension strength (p < 0.01), anaerobic capacity (p < 0.05), time to exhaustion (p < 0.01), all significantly increased | (+) |
Mahon et al. [24] | Mixed | Cycling | Work rate (exercise intensity) at peak exercise significantly higher with medication (p < 0.05) | (+) |
Summary of findings, with (+) indicating a significant difference identified and, (−) indicating no significant difference found